Cargando…
A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain
A bovine herpesvirus 1 (BoHV-1) defective in glycoprotein E (gE) was constructed from a Brazilian genital BoHV-1 isolate, by replacing the full gE coding region with the green fluorescent protein (GFP) gene for selection. Upon co-transfection of MDBK cells with genomic viral DNA plus the GFP-bearing...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568813/ https://www.ncbi.nlm.nih.gov/pubmed/26200229 http://dx.doi.org/10.1590/1414-431X20154243 |
_version_ | 1782389952176193536 |
---|---|
author | Weiss, M. Brum, M.C.S. Anziliero, D. Weiblen, R. Flores, E.F. |
author_facet | Weiss, M. Brum, M.C.S. Anziliero, D. Weiblen, R. Flores, E.F. |
author_sort | Weiss, M. |
collection | PubMed |
description | A bovine herpesvirus 1 (BoHV-1) defective in glycoprotein E (gE) was constructed from a Brazilian genital BoHV-1 isolate, by replacing the full gE coding region with the green fluorescent protein (GFP) gene for selection. Upon co-transfection of MDBK cells with genomic viral DNA plus the GFP-bearing gE-deletion plasmid, three fluorescent recombinant clones were obtained out of approximately 5000 viral plaques. Deletion of the gE gene and the presence of the GFP marker in the genome of recombinant viruses were confirmed by PCR. Despite forming smaller plaques, the BoHV-1△gE recombinants replicated in MDBK cells with similar kinetics and to similar titers to that of the parental virus (SV56/90), demonstrating that the gE deletion had no deleterious effects on replication efficacy in vitro. Thirteen calves inoculated intramuscularly with BoHV-1△gE developed virus neutralizing antibodies at day 42 post-infection (titers from 2 to 16), demonstrating the ability of the recombinant to replicate and to induce a serological response in vivo. Furthermore, the serological response induced by recombinant BoHV-1△gE could be differentiated from that induced by wild-type BoHV-1 by the use of an anti-gE antibody ELISA kit. Taken together, these results indicated the potential application of recombinant BoHV-1 △gE in vaccine formulations to prevent the losses caused by BoHV-1 infections while allowing for differentiation of vaccinated from naturally infected animals. |
format | Online Article Text |
id | pubmed-4568813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Associação Brasileira de Divulgação Científica |
record_format | MEDLINE/PubMed |
spelling | pubmed-45688132015-09-29 A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain Weiss, M. Brum, M.C.S. Anziliero, D. Weiblen, R. Flores, E.F. Braz J Med Biol Res Clinical Investigation A bovine herpesvirus 1 (BoHV-1) defective in glycoprotein E (gE) was constructed from a Brazilian genital BoHV-1 isolate, by replacing the full gE coding region with the green fluorescent protein (GFP) gene for selection. Upon co-transfection of MDBK cells with genomic viral DNA plus the GFP-bearing gE-deletion plasmid, three fluorescent recombinant clones were obtained out of approximately 5000 viral plaques. Deletion of the gE gene and the presence of the GFP marker in the genome of recombinant viruses were confirmed by PCR. Despite forming smaller plaques, the BoHV-1△gE recombinants replicated in MDBK cells with similar kinetics and to similar titers to that of the parental virus (SV56/90), demonstrating that the gE deletion had no deleterious effects on replication efficacy in vitro. Thirteen calves inoculated intramuscularly with BoHV-1△gE developed virus neutralizing antibodies at day 42 post-infection (titers from 2 to 16), demonstrating the ability of the recombinant to replicate and to induce a serological response in vivo. Furthermore, the serological response induced by recombinant BoHV-1△gE could be differentiated from that induced by wild-type BoHV-1 by the use of an anti-gE antibody ELISA kit. Taken together, these results indicated the potential application of recombinant BoHV-1 △gE in vaccine formulations to prevent the losses caused by BoHV-1 infections while allowing for differentiation of vaccinated from naturally infected animals. Associação Brasileira de Divulgação Científica 2015-07-21 /pmc/articles/PMC4568813/ /pubmed/26200229 http://dx.doi.org/10.1590/1414-431X20154243 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Investigation Weiss, M. Brum, M.C.S. Anziliero, D. Weiblen, R. Flores, E.F. A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain |
title | A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine
strain |
title_full | A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine
strain |
title_fullStr | A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine
strain |
title_full_unstemmed | A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine
strain |
title_short | A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine
strain |
title_sort | glycoprotein e gene-deleted bovine herpesvirus 1 as a candidate vaccine
strain |
topic | Clinical Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568813/ https://www.ncbi.nlm.nih.gov/pubmed/26200229 http://dx.doi.org/10.1590/1414-431X20154243 |
work_keys_str_mv | AT weissm aglycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain AT brummcs aglycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain AT anzilierod aglycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain AT weiblenr aglycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain AT floresef aglycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain AT weissm glycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain AT brummcs glycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain AT anzilierod glycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain AT weiblenr glycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain AT floresef glycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain |